Abstract:There is a critical need to generate functional hepatocytes to aid in liver repair and regeneration upon availability of a renewable, and potentially personalized, source of human hepatocytes (hHEP). Currently, the vast majority of primary hHEP are obtained from human tissue through cadavers. Recent advances in stem cell differentiation have opened up the possibility to obtain fully functional hepatocytes from embryonic or induced pluripotent stem cells, or adult stem cells. With respect to the latter, human bone marrow mesenchymal stromal cells (hBMSCs) can serve as a source of autogenetic and allogenic multipotent stem cells for liver repair and regeneration. A major aspect of hBMSC differentiation is the extracellular matrix (ECM) composition and, in particular, the role of glycosaminoglycans (GAGs) in the differentiation process. In this study, we examine the influence of four distinct culture conditions/protocols (T1-T4) on GAG composition and hepatic markers. α-Fetoprotein and hepatocyte nuclear factor-4α were expressed continually over 21 days of differentiation, as indicated by real time quantitative PCR analysis, while albumin (ALB) expression did not begin until day 21. Hepatocyte growth factor (HGF) appears to be more effective than activin A in promoting hepatic-like cells through the mesenchymal-epithelial transition, perhaps due to the former binding to the HGF receptor to form a unique complex that diversifies the biological functions of HGF. Of the four protocols tested, uniform hepatocyte-like morphological changes, ALB secretion, and glycogen storage were found to be highest with protocol T2, which involves both early- and late-stage combinations of growth factors. The total GAG profile of the hBMSC ECM is rich in heparan sulfate (HS) and hyaluronan, both of which fluctuate during differentiation. The GAG profile of primary hHEP showed an HS-rich ECM, and thus, it may be possible to guide hBMSC differentiation to more mature hepatocytes by controlling the GAG profile expressed by differentiating cells.

Analysis of glycosaminoglycans in stem cell glycomics.

Glycosaminoglycans (gags) and Gag Mimetics Regulate the Behavior of Stem Cell Differentiation

Changes in Glycosaminoglycan Structure on Differentiation of Human Embryonic Stem Cells Towards Mesoderm and Endoderm Lineages.

Glycan Modifications as Regulators of Stem Cell Fate

Glycosaminoglycanomics of Cultured Cells Using a Rapid and Sensitive LC-MS/MS Approach

Compositional and Structural Analysis of Glycosaminoglycans in Cell-Derived Extracellular Matrices

Cell-Based Microscale Isolation of Glycoaminoglycans for Glycomics Study.

Glycosaminoglycan Disaccharide Compositional Analysis of Cell-Derived Extracellular Matrices Using Liquid Chromatography-Tandem Mass Spectrometry.

Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy.

Glycans in stem cell regulation: from Drosophila tissue stem cells to mammalian pluripotent stem cells

Adult Mesenchymal Stem Cells in Presence of Glycosaminoglycans

Glycan Markers of Human Stem Cells Assigned with Beam Search Arrays.

Gangliosides and Their Role in Multilineage Differentiation of Mesenchymal Stem Cells

Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease

Remodeling of Glycosaminoglycans During Differentiation of Adult Human Bone Mesenchymal Stromal Cells Toward Hepatocytes.

Glycomic Analysis by Glycoprotein Immobilization for Glycan Extraction and Liquid Chromatography on Microfluidic Chip.

Glycosaminoglycan Remodeling During Chondrogenic Differentiation of Human Bone Marrow−/synovial-Derived Mesenchymal Stem/stromal Cells under Normoxia and Hypoxia

The Alterations and Roles of Glycosaminoglycans in Human Diseases

Synthetic Glycopolymers for Highly Efficient Differentiation of Embryonic Stem Cells into Neurons: Lipo- or Not?

Glycan Labeling and Analysis in Cells and in Vivo.

Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications